Skip to Main content Skip to Navigation
Journal articles

Stimulatory Effect of Tofacitinib on Bone Marrow Adipocytes Differentiation

Abstract : Background: Systemic inflammation is the main factor underlying secondary osteoporosis in patients with rheumatoid arthritis (RA). Janus kinase inhibitors (JAKi), such as tofacitinib (Tofa), can control systemic inflammation and may have beneficial effects on bone in various models. This might be due to direct effects on the bone microenvironment and not exclusively based on their anti-inflammatory function. Bone marrow adipocytes (BMAds) are abundant in the bone microenvironment. The effect of JAKi on BMAds is unknown, but evidence suggests that there is competition between human bone marrow-derived stromal cell (hBMSC) differentiation routes towards BMAds and osteoblasts (Ob) in osteoporosis. Objectives: The aims of the study are to determine whether Tofa influences BMAds and Ob derived from hBMSCs and to investigate the potential effects of Tofa on bone marrow adiposity in RA patients. Methods: To determine the effect of Tofa on cellular commitment, hBMSCs were differentiated to BMAds or OBs for 3 days together with Tofa at 200, 400, or 800 nM and TNFa. This study was also conducted using differentiated BMAds. The impact of Tofa was determined by gene and protein expression analysis and cell density monitoring. In parallel, in a pilot study of 9 RA patients treated with Tofa 5 mg twice a day (NCT04175886), the proton density fat fraction (PDFF) was measured using MRI at the lumbar spine at baseline and at 6 months. Results: In non-inflammatory conditions, the gene expression of Runx2 and Dlx5 decreased in Ob treated with Tofa (p <0.05). The gene expression of PPARg2, C/ EBPa, and Perilipin 1 were increased compared to controls (p <0.05) in BMAds treated with Tofa. Under inflammatory conditions, Tofa did not change the expression profiles of Ob compared to TNFa controls. In contrast, Tofa limited the negative effect of TNFa on BMAd differentiation (p <0.05). An increase in the density of differentiated BMAds treated
Document type :
Journal articles
Complete list of metadata

https://hal-ulco.archives-ouvertes.fr/hal-03716381
Contributor : Aline CLABAUT-CARUSO Connect in order to contact the contributor
Submitted on : Thursday, July 7, 2022 - 1:42:58 PM
Last modification on : Wednesday, July 13, 2022 - 8:25:55 AM

File

fendo-13-881699.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Jean-Guillaume Letarouilly, Julien Paccou, Sammy Badr, Christophe Chauveau, Odile Broux, et al.. Stimulatory Effect of Tofacitinib on Bone Marrow Adipocytes Differentiation. Frontiers, University of Nebraska Press, 2022, 13, pp.881699. ⟨10.3389/fendo.2022.881699⟩. ⟨hal-03716381⟩

Share

Metrics

Record views

0

Files downloads

0